Aidixi (disitamab vedotin) - Pfizer
DXC008 - Hangzhou DAC Biotech
Trodelvy (sacituzumab govitecan-hziy) - Gilead
MEDI3726 - ADC Therapeutics, AstraZeneca
MLN2704 - Takeda
vandortuzumab vedotin (RG7450) - Roche
ASG 5ME - Pfizer
BNT324 - BioNTech
ifinatamab deruxtecan (DS-7300) - Daiichi Sankyo, Merck (MSD)
vobramitamab duocarmazine (MGC018) - MacroGenics
Tivdak (tisotumab vedotin-tftv) - Genmab, Pfizer
ABBV-969 - AbbVie
JNJ-8177 - J&J
http://www.ncbi.nlm.nih.gov/pubmed/40859874
 
Haichao Chen; Jiacheng Xu; Jiatao Yao; Pengcheng Hu; Qi Ma; Yutao Ma
 
Aug 27, 2025
 
Next